Literature DB >> 2901817

Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies.

L J Couderc1, I Caubarrere, A Venet, J Magdeleine, A Jouanelle, F Danon, G Buisson, J C Vernant.   

Abstract

STUDY
OBJECTIVE: To determine the features of pulmonary involvement in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1.
DESIGN: Nonrandomized prospective case series.
SETTING: Tertiary care units in two university medical centers. PATIENTS: Consecutive sample of 21 patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 infection.
INTERVENTIONS: Chest roentgenogram and bronchoalveolar lavage were done in all patients. Fifteen patients had pulmonary function tests. Alveolar T-lymphocyte subsets were analysed in 10 patients and thoracic computed tomographic scans were done in 10 patients.
MEASUREMENTS AND MAIN RESULTS: All patients were free of clinical pulmonary symptoms and had normal chest roentgenograms. Thoracic computed tomographic scans were normal in 9 of 10 patients and showed mild interstitial pneumonitis in 1. Pulmonary function tests were within the normal range in 13 patients and showed a mild restrictive syndrome in 2. Eighteen patients had increased absolute numbers of alveolar lymphocytes (mean, 77 +/- 39 X 10(3) lymphocytes/mL; range, 13.5 X 10(3) to 259 X 10(3) lymphocytes/mL). Sixteen patients had percentages of alveolar lymphocytes higher than 20% of all alveolar cells (mean, 33.5 +/- 12.7; range, 9 to 69). In all 10 patients tested, 64.2% +/- 13.2% of alveolar lymphocytes were CD8+ cells.
CONCLUSIONS: Excessive absolute numbers and percentages of alveolar lymphocytes were observed in 18 and 16 patients, respectively. Most alveolar lymphocytes were CD8+ cells.

Entities:  

Mesh:

Year:  1988        PMID: 2901817     DOI: 10.7326/0003-4819-109-8-625

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

1.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).

Authors:  M Seki; J I Kadota; Y Higashiyama; K Iida; T Iwashita; E Sasaki; S Maesaki; K Tomono; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  HTLV-I-associated diseases.

Authors:  P A Bunn
Journal:  West J Med       Date:  1989-05

4.  Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.

Authors:  Y Higashiyama; S Katamine; S Kohno; H Mukae; S Hino; T Miyamoto; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.

Authors:  S Mori; A Mizoguchi; M Kawabata; H Fukunaga; K Usuku; I Maruyama; M Osame
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

6.  Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues.

Authors:  M Seki; Y Higashiyama; A Mizokami; J Kadota; R Moriuchi; S Kohno; Y Suzuki; K Takahashi; T Gojobori; S Katamine
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

7.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.

Authors:  Hiromitsu Teruya; Mariko Tomita; Masachika Senba; Chie Ishikawa; Maki Tamayose; Akiko Miyazato; Satomi Yara; Yuetsu Tanaka; Yoichiro Iwakura; Jiro Fujita; Naoki Mori
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

9.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

10.  Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.

Authors:  Lloyd Einsiedel; Hai Pham; Virginia Au; Saba Hatami; Kim Wilson; Tim Spelman; Hubertus Jersmann
Journal:  ERJ Open Res       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.